Lv1
38 积分 2025-10-24 加入
Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial
20天前
已完结
Induction Immune Checkpoint Inhibitors and Chemotherapy Before Definitive Chemoradiation Therapy for Patients With Bulky Unresectable Stage III Non-Small Cell Lung Cancer
20天前
已完结
The next generation of immunotherapies for lung cancers
1个月前
已完结
Spatial transcriptomics: integrating platforms and computational approaches for clinical insights
2个月前
已完结
Finding Rearrangements in the Cell-Free DNA Haystack
5个月前
已完结
Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non-Small Cell Lung Cancer: A Lung-MAP Study
5个月前
已完结
皖公网安备34019202002308
